| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017384485 |
| P356 | DOI | 10.1038/NATURE12526 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/nature12526 |
| P932 | PMC publication ID | 3795960 |
| P698 | PubMed publication ID | 24037376 |
| P5875 | ResearchGate publication ID | 256611579 |
| P50 | author | Ari B. Molofsky | Q56516057 |
| Steven J Van Dyken | Q57335130 | ||
| Emily E Thornton | Q38324001 | ||
| P2093 | author name string | Ajay Chawla | |
| Hong-Erh Liang | |||
| Richard M Locksley | |||
| Matthew F Krummel | |||
| Laurence E Cheng | |||
| Alexander Mohapatra | |||
| Jesse C Nussbaum | |||
| Jakob von Moltke | |||
| P2860 | cites work | c-Maf and JunB mediation of Th2 differentiation induced by the type 2 G protein-coupled receptor (VPAC2) for vasoactive intestinal peptide | Q46772245 |
| Entrainment to feeding but not to light: circadian phenotype of VPAC2 receptor-null mice. | Q48197811 | ||
| Meal timing dominates the lighting regimen as a synchronizer of the eosinophil rhythm in mice | Q67335487 | ||
| Eosinophil rhythm in mice: range of occurrence; effects of illumination, feeding, and adrenalectomy | Q73194011 | ||
| IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism | Q74599784 | ||
| Common gamma-chain-dependent signals confer selective survival of eosinophils in the murine small intestine | Q84754865 | ||
| Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161 | Q84933191 | ||
| Systemically dispersed innate IL-13-expressing cells in type 2 immunity | Q24623563 | ||
| Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity | Q24630261 | ||
| The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei | Q28207565 | ||
| Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells | Q29619771 | ||
| Spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to T cells in the lung | Q30515732 | ||
| Analysis of core circadian feedback loop in suprachiasmatic nucleus of mCry1-luc transgenic reporter mouse | Q30540490 | ||
| Fundamental signals that regulate eosinophil homing to the gastrointestinal tract | Q33853251 | ||
| Innate lymphoid cells: emerging insights in development, lineage relationships, and function | Q34245256 | ||
| The eosinophil | Q34503956 | ||
| Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis | Q35381048 | ||
| Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity | Q35624378 | ||
| Genetic analysis of basophil function in vivo. | Q35731933 | ||
| Gastrointestinal dysfunction in mice with a targeted mutation in the gene encoding vasoactive intestinal polypeptide: a model for the study of intestinal ileus and Hirschsprung's disease | Q36093506 | ||
| Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages | Q36694157 | ||
| IL-5 and eosinophilia. | Q37176808 | ||
| VPAC and PAC receptors: From ligands to function | Q37358588 | ||
| Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity | Q39427367 | ||
| The absence of the VPAC(2) receptor does not protect mice from Aspergillus induced allergic asthma | Q40640416 | ||
| The absence of VPAC2 leads to aberrant antibody production in Aspergillus fumigatus sensitized and challenged mice | Q41827983 | ||
| IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. | Q42514540 | ||
| Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice | Q42517634 | ||
| A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes | Q42675149 | ||
| Disrupted circadian rhythms in VIP- and PHI-deficient mice | Q44509581 | ||
| P433 | issue | 7470 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 4 | |
| P304 | page(s) | 245-248 | |
| P577 | publication date | 2013-09-15 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Type 2 innate lymphoid cells control eosinophil homeostasis | |
| P478 | volume | 502 |
| Q59350165 | A Major Population of Functional KLRG1 ILC2s in Female Lungs Contributes to a Sex Bias in ILC2 Numbers |
| Q89055227 | A Metabolite-Triggered Tuft Cell-ILC2 Circuit Drives Small Intestinal Remodeling |
| Q48208624 | A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis. |
| Q58100184 | A Transcriptomic Method to Determine Airway Immune Dysfunction in T2-High and T2-Low Asthma |
| Q90494825 | A circadian clock is essential for homeostasis of group 3 innate lymphoid cells in the gut |
| Q37611447 | A tissue checkpoint regulates type 2 immunity. |
| Q36052705 | A worm of one's own: how helminths modulate host adipose tissue function and metabolism |
| Q34979492 | Activated type 2 innate lymphoid cells regulate beige fat biogenesis |
| Q89545383 | Activation of group 2 innate lymphoid cells alleviates aging-associated cognitive decline |
| Q50086989 | Adenosine metabolism, immunity and joint health. |
| Q92058584 | Adventitial Stromal Cells Define Group 2 Innate Lymphoid Cell Tissue Niches |
| Q26775173 | Airway epithelial repair in health and disease: Orchestrator or simply a player? |
| Q38267982 | Airway responses towards allergens - from the airway epithelium to T cells. |
| Q88959784 | All along the watchtower: group 2 innate lymphoid cells in allergic responses |
| Q35164318 | Allergic inflammation--innately homeostatic |
| Q47132488 | Alternative activation generates IL-10 producing type 2 innate lymphoid cells |
| Q52927623 | Alveolar Epithelial Cell-Derived Mediators: Potential Direct Regulators of Large Airway and Vascular Responses. |
| Q59802868 | Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma |
| Q41605623 | Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma |
| Q39402910 | Are ILC2s Jekyll and Hyde in airway inflammation? |
| Q93182281 | Aryl Hydrocarbon Receptor Signaling Cell Intrinsically Inhibits Intestinal Group 2 Innate Lymphoid Cell Function |
| Q35115465 | At the bench: understanding group 2 innate lymphoid cells in disease. |
| Q26801045 | Barrier Epithelial Cells and the Control of Type 2 Immunity |
| Q98513800 | Basophils prime group 2 innate lymphoid cells for neuropeptide-mediated inhibition |
| Q58698606 | Benralizumab, an add-on treatment for severe eosinophilic asthma: evaluation of exacerbations, emergency department visits, lung function, and oral corticosteroid use |
| Q33759935 | Beyond NK cells: the expanding universe of innate lymphoid cells. |
| Q41098587 | Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer |
| Q52940038 | CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma. |
| Q35160658 | CCR7-dependent trafficking of RORγ⁺ ILCs creates a unique microenvironment within mucosal draining lymph nodes. |
| Q33918803 | CD300f:IL-5 cross-talk inhibits adipose tissue eosinophil homing and subsequent IL-4 production |
| Q38577294 | CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. |
| Q90661244 | Calcitonin Gene-Related Peptide Negatively Regulates Alarmin-Driven Type 2 Innate Lymphoid Cell Responses |
| Q34442444 | Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells |
| Q52626495 | Characterisation of innate lymphoid cell populations at different sites in mice with defective T cell immunity. |
| Q33604481 | Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and γδ T cells |
| Q35170797 | Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection |
| Q90541320 | Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation |
| Q64255994 | Chronic pulmonary aspergillosis may cause eosinophilic granulomatosis with polyangiitis via allergic bronchopulmonary aspergillosis |
| Q50779981 | Circadian Rhythms in Adipose Tissue Physiology. |
| Q88377323 | Clocking in to immunity |
| Q35329384 | Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia |
| Q38882799 | Colonization and effector functions of innate lymphoid cells in mucosal tissues |
| Q92721819 | Compartmentalized effects of aging on group 2 innate lymphoid cell development and function |
| Q36116749 | Composition, Development, and Function of Uterine Innate Lymphoid Cells |
| Q60642286 | Contributions of Innate Type 2 Inflammation to Adipose Function |
| Q38934964 | Control of brown and beige fat development |
| Q36440299 | Controlling the burn and fueling the fire: defining the role for the alarmin interleukin-33 in alloimmunity |
| Q99207898 | Critical Adjuvant Influences on Preventive Anti-Metastasis Vaccine Using a Structural Epitope Derived from Membrane Type Protease PRSS14 |
| Q35785264 | Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease |
| Q34455625 | Cutting edge: maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation |
| Q36881040 | Cytokine response during non-cerebral and cerebral malaria: evidence of a failure to control inflammation as a cause of death in African adults |
| Q91636313 | Cytokines and beyond: Regulation of innate immune responses during helminth infection |
| Q37377085 | DUOX1 mediates persistent epithelial EGFR activation, mucous cell metaplasia, and airway remodeling during allergic asthma |
| Q57471942 | DUSP10 constrains innate IL-33-mediated cytokine production in ST2 memory-type pathogenic Th2 cells |
| Q39030590 | Different Lymphocyte Populations Direct Dichotomous Eosinophil or Neutrophil Responses to Pulmonary Cryptococcus Infection |
| Q89525241 | Distinct and shared gene expression for human innate versus adaptive helper lymphoid cells |
| Q35967497 | Early Persistent Blood Eosinophilia in Necrotizing Enterocolitis Is a Predictor of Late Complications |
| Q47992979 | Effects of anticholinergic agent on miRNA profiles and transcriptomes in a murine model of allergic rhinitis |
| Q37346684 | Emerging concepts and future challenges in innate lymphoid cell biology |
| Q34111924 | Enhanced innate type 2 immune response in peripheral blood from patients with asthma |
| Q97067660 | Eomes Expression Defines Group 1 Innate Lymphoid Cells During Metastasis in Human and Mouse |
| Q41743992 | Eosinophil-derived IL-10 supports chronic nematode infection. |
| Q35757394 | Eosinophil-specific deletion of IκBα in mice reveals a critical role of NF-κB-induced Bcl-xL for inhibition of apoptosis. |
| Q99237529 | Eosinophilic Colitis and Clostridioides difficile Sepsis With Rapid Remission After Antimicrobial Treatment; A Rare Coincidence and Its Pathogenic Implications |
| Q55311740 | Eosinophils from Physiology to Disease: A Comprehensive Review. |
| Q38390424 | Eosinophils in mucosal immune responses |
| Q92323510 | Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders |
| Q36847447 | Eosinophils in vasculitis: characteristics and roles in pathogenesis |
| Q38801764 | Eosinophils, probiotics, and the microbiome. |
| Q47225787 | Eosinophils: The unsung heroes in cancer? |
| Q33874975 | Establishment and function of tissue-resident innate lymphoid cells in the skin |
| Q89681192 | Feeding-dependent VIP neuron-ILC3 circuit regulates the intestinal barrier |
| Q40474105 | Fibroblastic reticular cells regulate intestinal inflammation via IL-15-mediated control of group 1 ILCs. |
| Q38947692 | First-Breath-Induced Type 2 Pathways Shape the Lung Immune Environment |
| Q33843062 | Full Length Interleukin 33 Aggravates Radiation-Induced Skin Reaction. |
| Q40054108 | Functions of tissue-resident eosinophils |
| Q47105198 | GATA3 Regulates the Development and Functions of Innate Lymphoid Cell Subsets at Multiple Stages |
| Q40216791 | Globule Leukocytes and Other Mast Cells in the Mouse Intestine |
| Q87994387 | Gpr109a Limits Microbiota-Induced IL-23 Production To Constrain ILC3-Mediated Colonic Inflammation |
| Q35898996 | Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis |
| Q89965821 | Group 2 Innate Lymphoid Cells (ILC2) Suppress Beneficial Type 1 Immune Responses During Pulmonary Cryptococcosis |
| Q64108158 | Group 2 Innate Lymphoid Cells Are Redundant in Experimental Renal Ischemia-Reperfusion Injury |
| Q47095720 | Group 2 Innate Lymphoid Cells Exhibit a Dynamic Phenotype in Allergic Airway Inflammation |
| Q53818897 | Group 2 Innate Lymphoid Cells in Pulmonary Immunity and Tissue Homeostasis. |
| Q64981659 | Group 2 Innate Lymphoid Cells in Respiratory Allergic Inflammation. |
| Q89805617 | Group 2 Innate Lymphoid Cells: Central Players in a Recurring Theme of Repair and Regeneration |
| Q51074774 | Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia. |
| Q38573631 | Group 2 innate lymphoid cells in disease |
| Q38312434 | Group 2 innate lymphoid cells in health and disease |
| Q27021302 | Group 2 innate lymphoid cells in the lung |
| Q36421549 | Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis |
| Q27021604 | Group 2 innate lymphoid cells: new players in human allergic diseases |
| Q95840303 | Group-2 innate lymphoid cell-dependent regulation of tissue neutrophil migration by alternatively activated macrophage-secreted Ear11 |
| Q41918189 | Guidelines for the use of flow cytometry and cell sorting in immunological studies |
| Q37152701 | Hallmarks of Tissue-Resident Lymphocytes |
| Q37158737 | Heightened Immune Activation in Fetuses with Gastroschisis May Be Blocked by Targeting IL-5. |
| Q64244231 | Heterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua |
| Q41911216 | HiJAKing Innate Lymphoid Cells? |
| Q39458566 | Homeostatic Eosinophils: Characteristics and Functions |
| Q34257404 | Human CD117 (cKit)+ innate lymphoid cells have a discrete transcriptional profile at homeostasis and are expanded during filarial infection |
| Q98906910 | Human immunology and immunotherapy: main achievements and challenges |
| Q47099669 | Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. |
| Q26827479 | I-L-C-2 it: type 2 immunity and group 2 innate lymphoid cells in homeostasis |
| Q40652847 | ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice |
| Q51530407 | IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. |
| Q51430338 | IL-13+ Type 2 Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment Response. |
| Q37737853 | IL-15 sustains IL-7R-independent ILC2 and ILC3 development |
| Q53793238 | IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. |
| Q35023076 | IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice |
| Q34979676 | IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells. |
| Q39974669 | IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis. |
| Q37402019 | IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis |
| Q53668953 | IL-33 activates eosinophils of visceral adipose tissue both directly and via innate lymphoid cells. |
| Q92918310 | IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection |
| Q37410967 | IL-33 mediates reactive eosinophilopoiesis in response to airborne allergen exposure |
| Q47340483 | IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow. |
| Q36514695 | IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing |
| Q40348061 | IL-33-Mediated Expansion of Type 2 Innate Lymphoid Cells Protects from Progressive Glomerulosclerosis |
| Q47407422 | IL-33-Responsive Group 2 Innate Lymphoid Cells Are Regulated by Female Sex Hormones in the Uterus |
| Q38937386 | IL-33-driven ILC2/eosinophil axis in fat is induced by sympathetic tone and suppressed by obesity |
| Q37600819 | IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection. |
| Q40120480 | IL33-mediated ILC2 activation and neutrophil IL5 production in the lung response after severe trauma: A reverse translation study from a human cohort to a mouse trauma model. |
| Q90419317 | ILC2 Activation by Protozoan Commensal Microbes |
| Q64241174 | ILC2 Orchestration of Local Immune Function in Adipose Tissue |
| Q40051364 | ILC2s activated by IL-25 promote antigen-specific Th2 and Th9 functions that contribute to the control of Trichinella spiralis infection |
| Q38539058 | ILC2s and fungal allergy |
| Q92072232 | ILC2s: New Actors in Tumor Immunity |
| Q36520874 | ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation |
| Q92407437 | ILC3s gut rhythm |
| Q30629726 | Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease |
| Q91706529 | Immune Activation in Functional Gastrointestinal Disorders |
| Q38601401 | Immune dysregulation in the functional gastrointestinal disorders |
| Q39000249 | Immune modules shared by innate lymphoid cells and T cells |
| Q35450500 | Immune regulation of metabolic homeostasis in health and disease. |
| Q49347747 | Immunity to gastrointestinal nematode infections. |
| Q28242288 | Immunity to gastrointestinal nematodes: mechanisms and myths |
| Q58693435 | Immunological and hematological effects of IL-5(Rα)-targeted therapy: An overview |
| Q64915316 | Immunomodulatory Effects of the Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide in Acute Toxoplasmosis. |
| Q89965683 | Immunoregulatory Sensory Circuits in Group 3 Innate Lymphoid Cell (ILC3) Function and Tissue Homeostasis |
| Q38382162 | In situ hematopoiesis: a regulator of TH2 cytokine-mediated immunity and inflammation at mucosal surfaces |
| Q38202992 | Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases |
| Q64067619 | Inflammatory monocytes are detrimental to the host immune response during acute infection with Cryptococcus neoformans |
| Q50228830 | Innate Lymphoid Cell Immunometabolism. |
| Q90180992 | Innate Lymphoid Cell-Dependent Airway Epithelial and Inflammatory Responses to Inhaled Ozone: A New Paradigm in Pathogenesis |
| Q90044642 | Innate Lymphoid Cells Play a Pathogenic Role in Pericarditis |
| Q47554808 | Innate Lymphoid Cells in HIV/SIV Infections |
| Q64058682 | Innate Lymphoid Cells in Helminth Infections-Obligatory or Accessory? |
| Q89736312 | Innate Lymphoid Cells in Renal Inflammation |
| Q58707784 | Innate Lymphoid Cells in the Maternal and Fetal Compartments |
| Q64230647 | Innate Lymphoid Cells: A Link between the Nervous System and Microbiota in Intestinal Networks |
| Q89167818 | Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity |
| Q38221348 | Innate immunity in the lung regulates the development of asthma |
| Q38872152 | Innate lymphoid cell function in the context of adaptive immunity |
| Q28072425 | Innate lymphoid cell regulation of adaptive immunity |
| Q62733580 | Innate lymphoid cell sensing of tissue vitality |
| Q49980468 | Innate lymphoid cells and allergic disease. |
| Q38763067 | Innate lymphoid cells as novel regulators of obesity and its-associated metabolic dysfunction |
| Q38872144 | Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. |
| Q49861059 | Innate lymphoid cells at the human maternal-fetal interface in spontaneous preterm labor. |
| Q40062668 | Innate lymphoid cells at the interface between obesity and asthma. |
| Q94591730 | Innate lymphoid cells control signaling circuits to regulate tissue-specific immunity |
| Q36973089 | Innate lymphoid cells in asthma: Will they take your breath away? |
| Q38605374 | Innate lymphoid cells in intestinal immunity and inflammation |
| Q36908615 | Innate lymphoid cells in the initiation, regulation and resolution of inflammation |
| Q27023221 | Innate lymphoid cells in the skin |
| Q38295077 | Innate lymphoid cells in type 2 immune responses |
| Q88990558 | Innate lymphoid cells-key immune integrators of overall body homeostasis |
| Q35638915 | Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology |
| Q38916194 | Innate lymphoid cells: models of plasticity for immune homeostasis and rapid responsiveness in protection. |
| Q36288830 | Innate lymphoid cells: new insights into function and development |
| Q47186385 | Interactions between Innate Lymphoid Cells and Cells of the Innate and Adaptive Immune System |
| Q52594640 | Interactions of the immune and sensory nervous systems in atopy. |
| Q40971337 | Interferon-γ constrains cytokine production of group 2 innate lymphoid cells |
| Q47591113 | Interleukin (IL)-33 and the IL-1 Family of Cytokines-Regulators of Inflammation and Tissue Homeostasis. |
| Q38783993 | Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer |
| Q47285890 | Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family. |
| Q41149769 | Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation |
| Q35754479 | Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation |
| Q28067081 | Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs |
| Q34636874 | Interleukin-5-producing group 2 innate lymphoid cells control eosinophilia induced by interleukin-2 therapy. |
| Q48151041 | Interplay of innate lymphoid cells and the microbiota. |
| Q89481425 | Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma |
| Q64057019 | Intravital imaging allows real-time characterization of tissue resident eosinophils |
| Q40082836 | Isolation of Group 2 Innate Lymphoid Cells from Mouse Lungs |
| Q62002268 | Keeping eosinophils on time — ILC2 it! |
| Q98222237 | Keeping time in group 3 innate lymphoid cells |
| Q49661162 | Lineage specification in innate lymphocytes. |
| Q28276574 | Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets |
| Q89551915 | Living with Yourself: Innate Lymphoid Cell Immunometabolism |
| Q27687298 | Lymphocyte roles in metabolic dysfunction: of men and mice |
| Q26796071 | Maintenance of Immune Homeostasis through ILC/T Cell Interactions |
| Q34544937 | Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience |
| Q57826833 | Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience |
| Q90050659 | Metabolic Control of Innate Lymphoid Cell Migration |
| Q36999204 | Metabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction |
| Q46425558 | MicroRNA regulation of type 2 innate lymphoid cell homeostasis and function in allergic inflammation |
| Q36554706 | Migration and Tissue Tropism of Innate Lymphoid Cells |
| Q39402859 | Modeling TH 2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma |
| Q52682733 | Modulation of human airway smooth muscle biology by human adipocytes. |
| Q59387548 | Mouse models for the study of fate and function of innate lymphoid cells |
| Q92058744 | Mucosal Immunity in HIV/SIV Infection: T Cells, B Cells and Beyond |
| Q55332282 | Multi-Walled Carbon Nanotubes Augment Allergic Airway Eosinophilic Inflammation by Promoting Cysteinyl Leukotriene Production. |
| Q38919669 | NK Cells Alleviate Lung Inflammation by Negatively Regulating Group 2 Innate Lymphoid Cells. |
| Q39022829 | Natural killer cells in inflammatory heart disease. |
| Q39084322 | Negative Regulation of Type 2 Immunity |
| Q91711799 | Neuro-Immune Circuits Regulate Immune Responses in Tissues and Organ Homeostasis |
| Q92099072 | Neuro-immune crosstalk and allergic inflammation |
| Q90841043 | Neuro-immune regulation of mucosal physiology |
| Q57181221 | Neuroendocrine regulation of innate lymphoid cells |
| Q40431964 | Neuroimmune Modulation of Gut Function. |
| Q92059916 | Neuroimmune circuits in inter-organ communication |
| Q90699508 | Neuroimmunophysiology of the gut: advances and emerging concepts focusing on the epithelium |
| Q40067858 | Neuronal regulation of type 2 innate lymphoid cells via neuromedin U. |
| Q38400762 | New fronts emerge in the influenza cytokine storm |
| Q47960048 | Newly divided eosinophils limit ozone-induced airway hyperreactivity in nonsensitized guinea pigs. |
| Q34089159 | Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens. |
| Q34089174 | Nfil3 is required for the development of all innate lymphoid cell subsets. |
| Q42198317 | Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy. |
| Q36765897 | Novel Inhibitory Effect of a Lysophosphatidic Acid 2 Agonist on Allergen-Driven Airway Inflammation |
| Q91497015 | Obesity: a neuroimmunometabolic perspective |
| Q91816062 | Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses |
| Q39250716 | Origins and evolution of innate lymphoid cells: Wardens of barrier immunity |
| Q39147430 | PGI2 Controls Pulmonary NK Cells That Prevent Airway Sensitization to House Dust Mite Allergen |
| Q92384478 | Pain and immunity: implications for host defence |
| Q33876003 | Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma. |
| Q39564622 | Perinatal Licensing of Thermogenesis by IL-33 and ST2. |
| Q92052810 | Peripheral neurons: Master regulators of skin and mucosal immune response |
| Q38837172 | Pharmacological treatment of eosinophilic gastrointestinal disorders |
| Q64102318 | Physiological Regulation of Innate Lymphoid Cells |
| Q36373095 | Pleural cavity type 2 innate lymphoid cells precede Th2 expansion in murine Litomosoides sigmodontis infection |
| Q55097573 | Precision Medicine in Chronic Rhinosinusitis with Nasal Polyps. |
| Q47961875 | Prior Repeated Stress Attenuates Cold-Induced Immunomodulation Associated with "Browning" in Mesenteric Fat of Rats |
| Q50000630 | Progress in the understanding of the pathology of allergic asthma and the potential of fruit proanthocyanidins as modulators of airway inflammation. |
| Q51560377 | Prostacyclin as a Potential Novel Means to Manipulate Type 2 Innate Lymphoid Cell Function. |
| Q90140555 | Protocols for Studying Murine ILC Development |
| Q92595448 | Pulmonary environmental cues drive group 2 innate lymphoid cell dynamics in mice and humans |
| Q91142624 | Pulmonary group 2 innate lymphoid cells: surprises and challenges |
| Q88219606 | Pulmonary neuroendocrine cells amplify allergic asthma responses |
| Q92641374 | RAGE-induced ILC2 expansion in acute lung injury due to haemorrhagic shock |
| Q52729197 | RORα-expressing T regulatory cells restrain allergic skin inflammation. |
| Q28077915 | Recent advances in understanding and managing asthma |
| Q40130448 | Reduced numbers of circulating group 2 innate lymphoid cells in patients with common variable immunodeficiency. |
| Q34439411 | Regional specialization within the intestinal immune system |
| Q97521492 | Regulation of Human Innate Lymphoid Cells in the Context of Mucosal Inflammation |
| Q49544001 | Regulation of Innate Lymphoid Cells by Aryl Hydrocarbon Receptor. |
| Q34081391 | Regulation of intestinal health and disease by innate lymphoid cells |
| Q37313634 | Regulation of metabolic health and adipose tissue function by group 2 innate lymphoid cells |
| Q38629225 | Regulation of metabolism by the innate immune system |
| Q37677658 | Regulatory Eosinophils in Inflammation and Metabolic Disorders |
| Q39201543 | Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine? |
| Q28078290 | Reslizumab in the management of poorly controlled asthma: the data so far |
| Q38661881 | Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects |
| Q58778332 | Resolution of chronic inflammatory disease: universal and tissue-specific concepts |
| Q48289638 | Resolving a chronic inflammation mystery |
| Q35880427 | Retinoic Acid Differentially Regulates the Migration of Innate Lymphoid Cell Subsets to the Gut. |
| Q38831891 | Role of Eosinophil Granulocytes in Allergic Airway Inflammation Endotypes |
| Q49024849 | Role of NKp46+ natural killer cells in house dust mite-driven asthma. |
| Q64072583 | Role of innate lymphoid cells in allergic diseases |
| Q33711482 | Role of pro- and anti-inflammatory phenomena in the physiopathology of type 2 diabetes and obesity |
| Q34430214 | Roles and regulation of gastrointestinal eosinophils in immunity and disease |
| Q61118459 | Runx/Cbfβ complexes protect group 2 innate lymphoid cells from exhausted-like hyporesponsiveness during allergic airway inflammation |
| Q36818009 | Selective programming of CCR10(+) innate lymphoid cells in skin-draining lymph nodes for cutaneous homeostatic regulation |
| Q45401591 | Sense and Immunity: Context-Dependent Neuro-Immune Interplay. |
| Q92179686 | Sensing of physiological regulators by innate lymphoid cells |
| Q39117205 | Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence |
| Q48605548 | Sentinels of the Type 2 Immune Response. |
| Q47780445 | Sex differences in activation of lung-related type 2 innate lymphoid cells in experimental asthma |
| Q52719312 | Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease. |
| Q35862644 | Silencing Nociceptor Neurons Reduces Allergic Airway Inflammation. |
| Q59791476 | Social Networking of Group Two Innate Lymphoid Cells in Allergy and Asthma |
| Q57181199 | Spatial and temporal coordination of antiviral responses by group 1 ILCs |
| Q38826346 | Spontaneous Chitin Accumulation in Airways and Age-Related Fibrotic Lung Disease. |
| Q92537459 | Suppression of ILC2 differentiation from committed T cell precursors by E protein transcription factors |
| Q35148851 | Systemic impact of intestinal helminth infections |
| Q35940715 | T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production |
| Q57793461 | T-bet controls intestinal mucosa immune responses via repression of type 2 innate lymphoid cell function |
| Q89748053 | Targeted deletion of the TSLP receptor reveals cellular mechanisms that promote type 2 airway inflammation |
| Q97525836 | The Emerging Role of Eosinophils as Multifunctional Leukocytes in Health and Disease |
| Q42366429 | The Eosinophil Count Tends to Be Negatively Associated with Levels of Serum Glucose in Patients with Adrenal Cushing Syndrome. |
| Q98465722 | The Heterogeneity, Origins, and Impact of Migratory iILC2 Cells in Anti-helminth Immunity |
| Q91725370 | The Immune Function of Tuft Cells at Gut Mucosal Surfaces and Beyond |
| Q92239566 | The Influence of Innate Lymphoid Cells and Unconventional T Cells in Chronic Inflammatory Lung Disease |
| Q51835824 | The Innate Immune Response in Myocardial Infarction, Repair, and Regeneration. |
| Q92406465 | The Prostaglandin D2 Receptor CRTH2 Promotes IL-33-Induced ILC2 Accumulation in the Lung |
| Q36119050 | The Regulation of Immunological Processes by Peripheral Neurons in Homeostasis and Disease |
| Q38990422 | The Regulatory Function of Eosinophils |
| Q33790954 | The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases |
| Q38319907 | The biology of innate lymphoid cells |
| Q57039150 | The brave new world of innate lymphoid cells |
| Q27009449 | The cell biology of asthma |
| Q51088915 | The circadian protein BMAL1 in myeloid cells is a negative regulator of allergic asthma. |
| Q53705728 | The circadian regulator BMAL1 programmes responses to parasitic worm infection via a dendritic cell clock. |
| Q35629731 | The development of innate lymphoid cells requires TOX-dependent generation of a common innate lymphoid cell progenitor |
| Q28083968 | The differential expression of IL-4 and IL-13 and its impact on type-2 immunity |
| Q90208339 | The emerging roles of eosinophils in mucosal homeostasis |
| Q58611597 | The impact of allergen exposure and specific immunotherapy on circulating blood cells in allergic rhinitis |
| Q38271331 | The messenger between worlds: the regulation of innate and adaptive type-2 immunity by innate lymphoid cells |
| Q47095124 | The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation. |
| Q92229836 | The neuropeptide VIP confers anticipatory mucosal immunity by regulating ILC3 activity |
| Q38984914 | The obesity-related pathology and Th17 cells. |
| Q39215742 | The role of ILC2 in hookworm infection. |
| Q36663025 | The role of airway epithelial cells and innate immune cells in chronic respiratory disease |
| Q51483829 | The role of interleukin 5 in asthma. |
| Q89282567 | The roles for innate lymphoid cells in the human immune system |
| Q34485066 | The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosinophils |
| Q38478216 | The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD. |
| Q92435887 | The use of biologics for immune modulation in allergic disease |
| Q38969784 | Tissue Immunometabolism: Development, Physiology, and Pathobiology |
| Q39255569 | Tissue adaptation: Implications for gut immunity and tolerance. |
| Q64969347 | Tissue signals imprint ILC2 identity with anticipatory function. |
| Q97645042 | Tissue-resident lymphocytes: weaponized sentinels at barrier surfaces |
| Q89591411 | Tissue-specific pathways extrude activated ILC2s to disseminate type 2 immunity |
| Q64076242 | Transcription Factors in the Development and Function of Group 2 Innate Lymphoid Cells |
| Q36358937 | Transcription factor networks directing the development, function, and evolution of innate lymphoid effectors |
| Q90747862 | Transcriptional Atlas of Intestinal Immune Cells Reveals that Neuropeptide α-CGRP Modulates Group 2 Innate Lymphoid Cell Responses |
| Q26785671 | Transcriptional Regulatory Network for the Development of Innate Lymphoid Cells |
| Q37712418 | Transcriptional regulators dictate innate lymphoid cell fates |
| Q87454790 | Tuft cell-derived IL-25 activates and maintains ILC2 |
| Q34512467 | Tuft cells, taste-chemosensory cells, orchestrate parasite type 2 immunity in the gut. |
| Q36794704 | Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit |
| Q50025803 | Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis. |
| Q38216020 | Type 2 Innate Lymphoid Cells in Allergic Disease |
| Q64251722 | Type 2 Innate Lymphoid Cells in Liver and Gut: From Current Knowledge to Future Perspectives |
| Q49333301 | Type 2 cytokine responses: regulating immunity to helminth parasites and allergic inflammation. |
| Q99708206 | Type 2 cytokines IL-4 and IL-5 reduce severe outcomes from Clostridiodes difficile infection |
| Q40074887 | Type 2 immunity in tissue repair and fibrosis |
| Q57181216 | Type 2 innate lymphoid cells in the induction and resolution of tissue inflammation |
| Q26766464 | Type 2 innate lymphoid cells: at the cross-roads in allergic asthma |
| Q36299851 | Type 3 innate lymphoid cell depletion is mediated by TLRs in lymphoid tissues of simian immunodeficiency virus-infected macaques |
| Q38218882 | Update on innate lymphoid cells in atopic and non-atopic inflammation in the airways and skin |
| Q89167812 | Why Innate Lymphoid Cells? |
| Q91530400 | c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies |
| Q52718435 | γδ T cells producing interleukin-17A regulate adipose regulatory T cell homeostasis and thermogenesis. |
Search more.